MSTVIM
PARN

Messner & Smith Theme Value Investment Management’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Messner & Smith Theme Value Investment Management’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,000
Closed -$7K – 93
2016
Q4 		$7K Buy
+10,000
New +$11.9K 0.01% 77

Other funds holding PARN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Messner & Smith Theme Value Investment Management's PARN Position: Q1 2017 in Review

Messner & Smith Theme Value Investment Management sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 10,000 shares — an estimated $7K sold.

Messner & Smith Theme Value Investment Management first reported a position in PARN in Q4 2016 and held it in 1 quarter. The position peaked at $7K in Q4 2016. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

  • Messner & Smith Theme Value Investment Management reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
  • Messner & Smith Theme Value Investment Management sold 10,000 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017, an estimated $7K.
  • Messner & Smith Theme Value Investment Management first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q4 2016 and held it in 1 quarter.
  • Messner & Smith Theme Value Investment Management's Parnell Pharmaceuticals Holdings Ltd position peaked at $7K in Q4 2016.
  • 2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Messner & Smith Theme Value Investment Management's 13F filing for Q1 2017, filed 9 May 2017.